William Blair Equities Analysts Raise Earnings Estimates for Masimo Co. (MASI)
Masimo Co. (NASDAQ:MASI) – Investment analysts at William Blair increased their FY2018 earnings per share estimates for Masimo in a research report issued to clients and investors on Wednesday. William Blair analyst B. Weinstein now forecasts that the medical equipment provider will earn $2.80 per share for the year, up from their prior forecast of $2.52.
Other analysts have also issued research reports about the stock. Zacks Investment Research lowered shares of Masimo from a “buy” rating to a “hold” rating in a research report on Wednesday, February 7th. Piper Jaffray Companies reaffirmed a “hold” rating and set a $91.00 price target on shares of Masimo in a research report on Thursday. BidaskClub raised shares of Masimo from a “sell” rating to a “hold” rating in a research report on Thursday. Finally, Stifel Nicolaus reaffirmed a “buy” rating and set a $108.00 price target on shares of Masimo in a research report on Friday, November 3rd. Three research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. The stock has an average rating of “Buy” and an average price target of $102.33.
Masimo (NASDAQ:MASI) last released its earnings results on Tuesday, February 27th. The medical equipment provider reported $0.72 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.61 by $0.11. Masimo had a net margin of 16.49% and a return on equity of 22.91%. The business had revenue of $225.20 million for the quarter, compared to analyst estimates of $201.54 million. During the same period last year, the company posted $0.46 EPS. The business’s revenue was up 22.9% on a year-over-year basis.
In related news, Director Sanford Fitch sold 2,000 shares of Masimo stock in a transaction that occurred on Thursday, January 25th. The shares were sold at an average price of $90.00, for a total value of $180,000.00. Following the completion of the sale, the director now owns 70,249 shares in the company, valued at approximately $6,322,410. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Yongsam Lee sold 10,000 shares of Masimo stock in a transaction that occurred on Friday, January 5th. The shares were sold at an average price of $88.17, for a total transaction of $881,700.00. Following the completion of the sale, the executive vice president now owns 75,018 shares of the company’s stock, valued at approximately $6,614,337.06. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 42,198 shares of company stock worth $3,794,232. Corporate insiders own 16.60% of the company’s stock.
Institutional investors have recently bought and sold shares of the stock. Bank of New York Mellon Corp increased its holdings in Masimo by 6.4% in the 3rd quarter. Bank of New York Mellon Corp now owns 1,074,648 shares of the medical equipment provider’s stock valued at $93,021,000 after purchasing an additional 64,882 shares during the last quarter. Eagle Asset Management Inc. increased its holdings in Masimo by 6.1% in the 3rd quarter. Eagle Asset Management Inc. now owns 32,772 shares of the medical equipment provider’s stock valued at $2,847,000 after purchasing an additional 1,870 shares during the last quarter. Public Employees Retirement System of Ohio increased its holdings in Masimo by 143.1% in the 3rd quarter. Public Employees Retirement System of Ohio now owns 37,045 shares of the medical equipment provider’s stock valued at $3,207,000 after purchasing an additional 21,807 shares during the last quarter. Nine Chapters Capital Management LLC acquired a new stake in Masimo in the 3rd quarter valued at approximately $545,000. Finally, Fox Run Management L.L.C. acquired a new stake in Masimo in the 4th quarter valued at approximately $835,000. Hedge funds and other institutional investors own 82.18% of the company’s stock.
WARNING: This article was first published by Daily Political and is the property of of Daily Political. If you are accessing this article on another website, it was illegally copied and reposted in violation of U.S. and international trademark & copyright legislation. The correct version of this article can be viewed at https://www.dailypolitical.com/2018/03/03/william-blair-equities-analysts-raise-earnings-estimates-for-masimo-co-masi.html.
Masimo Company Profile
Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.
Receive News & Ratings for Masimo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo and related companies with MarketBeat.com's FREE daily email newsletter.